Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light.

PubWeight™: 2.62‹?› | Rank: Top 1%

🔗 View Article (PMC 2188768)

Published in J Exp Med on December 01, 1990

Authors

A Köck1, T Schwarz, R Kirnbauer, A Urbanski, P Perry, J C Ansel, T A Luger

Author Affiliations

1: Department of Dermatology II, University of Vienna, Austria.

Articles citing this

Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. Immunology (1992) 3.09

The protective role of melanin against UV damage in human skin. Photochem Photobiol (2008) 2.45

Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest (1992) 1.88

Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology (1995) 1.86

NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK. Genes Dev (2004) 1.85

Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J Cell Biol (1998) 1.75

Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med (1994) 1.66

Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med (1991) 1.62

Cytokine signaling mediates UV-induced nociceptive sensitization in Drosophila larvae. Curr Biol (2009) 1.56

Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. Evidence for increased cell viability and suppression of cytokine release. J Clin Invest (1995) 1.49

Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis. Proc Natl Acad Sci U S A (1995) 1.46

Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis. Am J Pathol (1993) 1.42

The role of inflammatory mediators in the pathogenesis of otitis media and sequelae. Clin Exp Otorhinolaryngol (2008) 1.36

Modulation of epidermal Langerhans' cell frequency by tumour necrosis factor-alpha. Immunology (1994) 1.33

Transcriptional control of the TNF gene. Curr Dir Autoimmun (2010) 1.32

Light, including ultraviolet. J Autoimmun (2009) 1.28

Anti-inflammatory and Anti-oxidative Effects of Korean Red Ginseng Extract in Human Keratinocytes. Immune Netw (2011) 1.28

Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med (1995) 1.19

Extinction of the tumor necrosis factor locus, and of genes encoding the lipopolysaccharide signaling pathway. J Exp Med (1993) 1.10

The effect of ultraviolet B irradiation and urocanic acid isomers on dendritic cell migration. Immunology (1992) 1.09

Role of tumour necrosis factor-alpha in ultraviolet B light-induced dendritic cell migration and suppression of contact hypersensitivity. Immunology (1994) 1.09

The MC160 protein expressed by the dermatotropic poxvirus molluscum contagiosum virus prevents tumor necrosis factor alpha-induced NF-kappaB activation via inhibition of I kappa kinase complex formation. J Virol (2006) 1.05

The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation. J Clin Invest (1993) 1.01

Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor. Clin Exp Immunol (1993) 1.01

A role for NF-kappaB-dependent gene transactivation in sunburn. J Clin Invest (2000) 1.01

Down-regulation of interferon gamma-activated STAT1 by UV light. Proc Natl Acad Sci U S A (1997) 0.99

Immunohistological and immunoelectron microscopic identification of TNF alpha in normal human and murine epidermis. Arch Dermatol Res (1992) 0.98

Permeability barrier disruption alters the localization and expression of TNF alpha/protein in the epidermis. Arch Dermatol Res (1994) 0.96

UVB and proinflammatory cytokines synergistically activate TNF-alpha production in keratinocytes through enhanced gene transcription. J Invest Dermatol (2008) 0.95

Modulation of ultraviolet-induced hyperalgesia and cytokine upregulation by interleukins 10 and 13. Br J Pharmacol (2000) 0.93

Innate immune responses in house dust mite allergy. ISRN Allergy (2013) 0.92

The Expression of Toll-like Receptors in Dermatological Diseases and the Therapeutic Effect of Current and Newer Topical Toll-like Receptor Modulators. J Clin Aesthet Dermatol (2010) 0.91

Examination of early interactions between Haemophilus ducreyi and host cells by using cocultured HaCaT keratinocytes and foreskin fibroblasts. Infect Immun (1999) 0.91

Simultaneous detection of eight cytokines in human dermal wounds with a multiplex bead-based immunoassay for wound age estimation. Int J Legal Med (2007) 0.90

Distinct effects of ultraviolet B light on antioxidant expression in undifferentiated and differentiated mouse keratinocytes. Carcinogenesis (2007) 0.90

The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer development. Cancer Res (2008) 0.90

A microarray analysis of temporal gene expression profiles in thermally injured human skin. Burns (2009) 0.90

[Chronic blepharitis. Pathogenesis, clinical features, and therapy]. Ophthalmologe (2007) 0.88

Analysis of tumor necrosis factor promoter responses to ultraviolet light. J Clin Invest (1994) 0.88

Pruritus in cutaneous T-cell lymphoma: a review. J Am Acad Dermatol (2012) 0.87

Cutaneous endothelin-A receptors elevate post-incisional pain. Pain (2007) 0.87

Low-dose UVB contributes to host resistance against Leishmania amazonensis infection in mice through induction of gamma interferon and tumor necrosis factor alpha cytokines. Clin Diagn Lab Immunol (2002) 0.85

Tumour necrosis factor alpha is expressed in refractory skin lesions from patients with subacute cutaneous lupus erythematosus. Ann Rheum Dis (2005) 0.85

Inhibitory effect of Korean Red Ginseng on melanocyte proliferation and its possible implication in GM-CSF mediated signaling. J Ginseng Res (2013) 0.85

Detection of in vivo production of tumour necrosis factor-alpha by human thyroid epithelial cells. Immunology (1992) 0.83

The Role of Macrophage Migration Inhibitory Factor (MIF) in Ultraviolet Radiation-Induced Carcinogenesis. Cancers (Basel) (2010) 0.82

Expression of tumor necrosis factor-alpha and its mRNA in the endometrial mucosa during the menstrual cycle. Am J Pathol (1993) 0.82

IL-2, IL-5, TNF-α and IFN-γ mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesions. Clinics (Sao Paulo) (2011) 0.82

Affinity cytochemistry analysis of mast cells in skin lesions: a possible tool to assess the timing of lesions after death. Int J Legal Med (2003) 0.82

Serum concentration of interleukin-6 is increased both in active and remission stages of pemphigus vulgaris. Mediators Inflamm (2008) 0.81

Tretinoin: A Review of Its Anti-inflammatory Properties in the Treatment of Acne. J Clin Aesthet Dermatol (2011) 0.80

Photoimmunology. Dermatol Clin (2014) 0.80

Effect of low-dose ultraviolet-B radiation on the function of human T lymphocytes in vitro. Clin Exp Immunol (1993) 0.80

The epidermal growth factor receptor increases cytokine production and cutaneous inflammation in response to ultraviolet irradiation. ISRN Dermatol (2013) 0.80

Photosensitivity in cutaneous lupus erythematosus. Photodermatol Photoimmunol Photomed (2013) 0.79

12(S)-Hydroxyheptadeca-5Z,8E,10E-trienoic acid suppresses UV-induced IL-6 synthesis in keratinocytes, exerting an anti-inflammatory activity. Exp Mol Med (2012) 0.79

Role of keratinocyte injury in adherence of Streptococcus pyogenes. Infect Immun (1999) 0.79

Characterization of the immunogenetic basis of ultraviolet-B light effects on contact hypersensitivity induction. Immunology (1994) 0.79

UVB-induced skin inflammation and cutaneous tissue injury is dependent on the MHC class I-like protein, CD1d. J Invest Dermatol (2013) 0.78

Epidermal platelet-activating factor receptor activation and ultraviolet B radiation result in synergistic tumor necrosis factor-alpha production. Photochem Photobiol (2009) 0.78

Time-course study of different innate immune mediators produced by UV-irradiated skin: comparative effects of short and daily versus a single harmful UV exposure. Immunology (2015) 0.78

Repeated doses of UVR cause minor alteration in cytokine serum levels in humans. Mediators Inflamm (2005) 0.78

Interleukin-1α Induction in Human Keratinocytes (HaCaT): An In Vitro Model for Chemoprevention in Skin. J Skin Cancer (2012) 0.77

Pseudomonas-derived ceramidase induces production of inflammatory mediators from human keratinocytes via sphingosine-1-phosphate. PLoS One (2014) 0.77

Effect of various metals on intercellular adhesion molecule-1 expression and tumour necrosis factor alpha production by normal human keratinocytes. Arch Dermatol Res (1994) 0.77

Disruption of TNF-α/TNFR1 function in resident skin cells impairs host immune response against cutaneous vaccinia virus infection. J Invest Dermatol (2012) 0.76

Thrombomodulin promotes diabetic wound healing by regulating toll-like receptor 4 expression. J Invest Dermatol (2015) 0.76

Epidermal Dysfunction Leads to an Age-Associated Increase in Levels of Serum Inflammatory Cytokines. J Invest Dermatol (2017) 0.75

Skin photoprotective and antiageing effects of a combination of rosemary (Rosmarinus officinalis) and grapefruit (Citrus paradisi) polyphenols. Food Nutr Res (2016) 0.75

Elevated levels of soluble tumour necrosis factor receptor I in blister fluids of bullous pemphigoid and suction blisters. Arch Dermatol Res (1994) 0.75

Drosophila caspase activity is required independently of apoptosis to produce active TNF/Eiger during nociceptive sensitization. Cell Death Dis (2017) 0.75

Role of Ceramide from Glycosphingolipids and Its Metabolites in Immunological and Inflammatory Responses in Humans. Mediators Inflamm (2015) 0.75

Progression of toxic epidermal necrolysis after tanning bed exposure. Arch Dermatol (2011) 0.75

Effect of Infliximab on the UVB-Induced Apoptosis of Keratinocytes Infected by HPV38 E6/E7. ISRN Dermatol (2013) 0.75

The effect of treadmill exercise on inflammatory responses in rat model of streptozotocin-induced experimental dementia of Alzheimer's type. J Exerc Nutrition Biochem (2014) 0.75

Topical Administration of Manuka Oil Prevents UV-B Irradiation-Induced Cutaneous Photoaging in Mice. Evid Based Complement Alternat Med (2013) 0.75

Characterization of a human skin equivalent model to study the effects of ultraviolet B radiation on keratinocytes. Tissue Eng Part C Methods (2014) 0.75

Serine protease inhibition attenuates rIL-12-induced GZMA activity and proinflammatory events by modulating the Th2 profile from estrogen-treated mice. Endocrinology (2014) 0.75

Lupus Skin Is Primed for IL-6 Inflammatory Responses through a Keratinocyte-Mediated Autocrine Type I Interferon Loop. J Invest Dermatol (2016) 0.75

Endotoxin-induced tumor necrosis factor alpha synthesis in murine embryo fibroblasts. Infect Immun (1993) 0.75

Inhibitory effects of ginsenosides on basic fibroblast growth factor-induced melanocyte proliferation. J Ginseng Res (2016) 0.75

Articles cited by this

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature (1985) 13.04

Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med (1985) 11.14

Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature (1986) 11.09

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med (1986) 10.91

Cachectin: more than a tumor necrosis factor. N Engl J Med (1987) 8.74

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med (1985) 8.16

Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol (1985) 7.20

Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med (1986) 5.17

Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc Natl Acad Sci U S A (1986) 5.03

Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med (1988) 4.79

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J Exp Med (1987) 3.62

Macrophages as a source of tumoricidal activity (tumor-necrotizing factor). Infect Immun (1980) 3.41

The role of cachectin/TNF in endotoxic shock and cachexia. Immunol Today (1988) 3.40

Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation. J Exp Med (1990) 2.82

Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1 alpha and beta mRNA. Keratinocyte epidermal cell-derived thymocyte-activating factor is identical to interleukin 1. J Exp Med (1986) 2.62

In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-alpha and interferon-gamma. J Immunol (1988) 2.21

Supergene families meet in the immune system. Immunol Today (1989) 1.78

Serum-free in vitro bioassay for the detection of tumor necrosis factor. J Immunol Methods (1986) 1.77

Immunological unresponsiveness induced by ultraviolet radiation. Immunol Rev (1984) 1.65

IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J Immunol (1989) 1.54

Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha. J Immunol (1988) 1.53

Ultraviolet light induces increased circulating interleukin-6 in humans. J Invest Dermatol (1990) 1.42

Immunohistological detection of interleukin I-like molecules and tumour necrosis factor in human epidermis before and after UVB-irradiation in vivo. Br J Dermatol (1988) 1.41

The expression and modulation of IL-1 alpha in murine keratinocytes. J Immunol (1988) 1.25

Effect of UV irradiation on epidermal cell cytokine production. J Photochem Photobiol B (1989) 1.12

Binding of recombinant interleukin-1 beta to the third complement component and alpha 2-macroglobulin after activation of serum by immune complexes. Blood (1990) 0.95

Articles by these authors

New Giemsa method for the differential staining of sister chromatids. Nature (1974) 7.38

Differences in the localization and morphology of chromosomes in the human nucleus. J Cell Biol (1999) 6.35

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol (1995) 4.14

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J Virol (1996) 3.66

Cytological detection of mutagen-carcinogen exposure by sister chromatid exchange. Nature (1975) 3.58

Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today (1998) 3.12

Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1. J Immunol (1982) 2.90

Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF). J Immunol (1981) 2.74

Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell (2000) 2.70

Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins. J Virol (1994) 2.52

Update on the use of ciclosporin in immune-mediated dermatoses. Br J Dermatol (2006) 2.49

Interaction of papillomaviruses with the cell surface. J Virol (1994) 2.44

Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J Infect Dis (1995) 2.21

Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool. Arch Dermatol (1999) 2.19

Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier's disease. Clin Infect Dis (2001) 2.14

Genital human papillomavirus infection. Proc Natl Acad Sci U S A (1994) 2.12

Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus. Br J Dermatol (2010) 2.12

Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells. J Immunol (1983) 2.03

Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition. J Virol (1996) 1.94

Differential Giemsa staining of sister chromatids and the study of chromatid exchanges without autoradiography. Chromosoma (1974) 1.94

Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Immunol Today (1995) 1.91

Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J Immunol (1999) 1.81

Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J Cell Biol (1998) 1.75

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67

Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope. J Virol (1997) 1.66

Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology (1994) 1.64

Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension. Br J Dermatol (2008) 1.64

Rivaroxaban prevents painful cutaneous infarctions in livedoid vasculopathy. Br J Dermatol (2013) 1.63

Localization of the 26S proteasome during mitosis and meiosis in fission yeast. EMBO J (1998) 1.61

Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol (1995) 1.59

Cytokine modulation of keratinocyte cytokines. J Invest Dermatol (1990) 1.59

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model. Proc Natl Acad Sci U S A (1998) 1.59

The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells. Invest Ophthalmol Vis Sci (2001) 1.55

IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J Immunol (1989) 1.54

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy (2006) 1.54

Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans. Drug Metab Dispos (2009) 1.53

Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. BMJ (1996) 1.51

Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. Evidence for increased cell viability and suppression of cytokine release. J Clin Invest (1995) 1.49

Evidence for an epidermal cytokine network. J Invest Dermatol (1990) 1.48

Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol (1999) 1.45

[Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients]. Hautarzt (2004) 1.42

Ultraviolet light induces increased circulating interleukin-6 in humans. J Invest Dermatol (1990) 1.42

[Drug reaction to amoxicillin simulating toxic pustuloderma]. Hautarzt (1991) 1.42

Molecular mechanisms of UV-induced apoptosis. Photodermatol Photoimmunol Photomed (2000) 1.41

Treatment of urticaria pigmentosa using interferon alpha. Br J Dermatol (1995) 1.40

Psoriasis vulgaris treated successfully with mycophenolate mofetil. Br J Dermatol (1998) 1.40

Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40

Diagnosis of bone infection using 99m Tc-HMPAO labelled leukocytes. Nucl Med Commun (2001) 1.40

Valve surgery combined with coronary artery operation: is the use of internal mammary artery a predictor for early complications? Eur J Cardiothorac Surg (1996) 1.39

Validation of Dermaphot(®) for the assessment of steroid-induced skin atrophy. Arch Dermatol Res (2012) 1.38

Responder cells in the human autologous mixed lymphocyte reaction. J Clin Invest (1981) 1.37

Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture. J Clin Invest (1982) 1.33

Antibodies to defined histone epitopes reveal variations in chromatin conformation and underacetylation of centric heterochromatin in human metaphase chromosomes. Chromosoma (1992) 1.33

Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor. J Virol (1995) 1.32

Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30

Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J Clin Invest (1994) 1.29

Evidence for the assignment of the loci AK1, AK3 and ACONs to chromosome 9 in man. Ann Hum Genet (1976) 1.29

Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity. J Leukoc Biol (2008) 1.28

IFN-beta 2/IL-6 augments the activity of human natural killer cells. J Immunol (1989) 1.28

In vitro correction of the interleukin 2 defect of autoimmune mice. Eur J Immunol (1983) 1.27

Increased thymocyte-activating factor in human gingival fluid during gingival inflammation. Infect Immun (1982) 1.27

Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. J Infect Dis (1995) 1.27

The expression and modulation of IL-1 alpha in murine keratinocytes. J Immunol (1988) 1.25

Mycosis fungoides: a dermatological masquerader. Br J Dermatol (2007) 1.24

Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J Immunol (1995) 1.24

UVB light induces nuclear factor kappa B (NF kappa B) activity independently from chromosomal DNA damage in cell-free cytosolic extracts. J Invest Dermatol (1994) 1.23

Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22

Ultraviolet-B-induced apoptosis of keratinocytes: evidence for partial involvement of tumor necrosis factor-alpha in the formation of sunburn cells. J Invest Dermatol (1995) 1.20

Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J Exp Med (2001) 1.17

Divergent human papillomavirus type 16 variants are serologically cross-reactive. J Infect Dis (1995) 1.17

Regulation of epidermal cell interleukin-6 production by UV light and corticosteroids. J Invest Dermatol (1991) 1.17

Scaffold attachments within the human genome. J Cell Sci (1997) 1.17

A possible screening test for inherited p53-related defects based on the apoptotic response of peripheral blood lymphocytes to DNA damage. Br J Cancer (1995) 1.17

Identification of alpha 2-macroglobulin as a cytokine binding plasma protein. Binding of interleukin-1 beta to "F" alpha 2-macroglobulin. J Biol Chem (1989) 1.17

Nuclear and cell membrane effects contribute independently to the induction of apoptosis in human cells exposed to UVB radiation. Proc Natl Acad Sci U S A (1999) 1.16

Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. Immunology (1994) 1.16

Ultraviolet irradiation induces the production of multiple cytokines by human corneal cells. Invest Ophthalmol Vis Sci (1997) 1.15